Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexia
about
Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatmentSarcopenic obesity: how do we treat it?Muscle wasting: an overview of recent developments in basic research.Moving on up: the Journal of Cachexia, Sarcopenia and Muscle.LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFα treatment.Cancer cachexia update in head and neck cancer: Pathophysiology and treatment.Leucine-rich diet alters the (1)H-NMR based metabolomic profile without changing the Walker-256 tumour mass in ratsPost-translationally modified muscle-specific ubiquitin ligases as circulating biomarkers in experimental cancer cachexia.Syngeneic B16F10 Melanoma Causes Cachexia and Impaired Skeletal Muscle Strength and Locomotor Activity in Mice.Pyrrolidine Dithiocarbamate (PDTC) Attenuates Cancer Cachexia by Affecting Muscle Atrophy and Fat Lipolysis.Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism.Phenotypes of Obesity: How it Impacts Management.The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting.
P2860
Q26775254-4683DD7D-3083-42C6-B7F0-7BC176726050Q27011411-2A3D7640-5EAA-4324-817F-19EC7229940FQ34156942-5E5E83D6-8D42-4B8B-9DCE-BAE4AB78B476Q34495485-7F153BE9-B1C5-4B23-8913-30550F18993FQ34855603-4A34D00F-893B-4BAF-8FF5-D9B79C1B1EBCQ35122201-EBC23654-F7BA-4DC6-B814-DAAC7CB10BB8Q36156782-9C317EE1-7A39-415B-812C-8650D1FF5D35Q42033093-17B388FD-1123-45C2-BF8D-D31B3A25B099Q42369823-EBB21B9A-813F-444E-ABB3-CB3504E28238Q47233582-3177D7BA-3E5B-4F3A-BD9C-BE78768A90BCQ48155681-CFEB2B89-B0BC-4D31-BC9B-04814E6443ABQ49834355-039FF762-D72A-4A7A-8978-EDA5F2B9C00DQ55653938-04A1F3F3-09F3-452A-9A2B-3C3A5C9599CA
P2860
Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexia
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Metabolic derangements in the ...... urine model of cancer cachexia
@en
type
label
Metabolic derangements in the ...... urine model of cancer cachexia
@en
prefLabel
Metabolic derangements in the ...... urine model of cancer cachexia
@en
P2093
P2860
P1476
Metabolic derangements in the ...... urine model of cancer cachexia
@en
P2093
Ashley Wysong
Hirak Der-Torossian
Jonathan McDunn
Marion E Couch
Scott Shadfar
P2860
P2888
P304
P356
10.1007/S13539-012-0101-7
P50
P577
2013-01-24T00:00:00Z